{"retracted":false,"update":{"timestamp":1464739200000,"doi":"10.1016/j.ejca.2016.03.007","type":"err"},"doi":"10.1016/j.ejca.2015.11.001","journal":"European Journal of Cancer","publisher":"Elsevier BV","title":"Corrigendum to “Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer” [Eur J Cancer 53 (2016) 51–64]"}
